Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

3SCTS
3SCTS
Home
Times are shown in your local time zone GMT
Speaker Profile Image

Professor Rob Baker

Professional Bio

Director of Perfusion and Cardiac Surgery Quality and Outcomes, Flinders Medical Center and Flinders University – Bedford Park, Adelaide, South Australia

Rob Baker is the Director of Perfusion and Quality and Outcomes in the Cardiothoracic Surgical Unit at Flinders, and was a foundation member of the team to commence Cardiac Surgery and Liver Transplantation at Flinders in 1992.  Rob completed his PhD in 1996 and his Perfusion CCP in 1998.  Rob works as part of the perfusion team at Flinders Medical Centre dedicated to improving patient outcomes through better perfusion practises.  He has published over 130 papers in the peer reviewed literature in both extracorporeal technology and more broadly in Cardiac Surgery.  His areas of interest include registry, evidence based practices, development and utilisation of perfusion standards and guidelines, benchmarking in cardiopulmonary bypass, blood management, acute kidney injury and cardiac surgery outcomes.  Rob is the current President of Australian and New Zealand College of Perfusionists, and was involved with AmSECT’s International Consortium for Evidence Based Perfusion for many years.  Rob chairs the Australian and New Zealand Collaborative Perfusion Registry, and is involved in a number of clinical registries, having established the Flinders Cardiac Surgery Registry in 1992.  He is a currently co-chair of the multidisciplinary STS/SCA/AmSECT Perfusion Task Force involved in developing Guideline for clinical practice. Rob has given more than 100 invited presentations at National and International meetings and has a number of awards, most notably the 2017 John H Gibbon Jr Award.
 
Rob has been involved as local project PI on a number of international trials related to blood management in cardiac surgery including the ITACS Trial (iron transfusion in cardiac surgery), TRICS IV trial (which has not yet commenced) and a number of commercially supported trials.  In addition Flinders Cardiac Surgery has worked extensively in the outcomes of indigenous patients undergoing cardiac surgery and has been an active participant in the Lighthouse suite of projects improving the Aboriginal and Torres Strait Islander (ATSI) People’s pathway through hospital when presenting with Acute Coronary Syndrome.